---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-006243"
form_type: "8-K"
ticker: "FLGT"
cik: "0001674930"
company_name: "Fulgent Genetics, Inc."
filed_at: "2022-02-23T23:59:59+00:00"
generated_at: "2026-06-27T05:32:27.996730+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Fulgent Genetics Q4 revenue $251.7M, full year 2021 revenue $992.6M, core revenue up 236% YoY

## Summary
- Q4 revenue $251.7M; full year 2021 revenue $992.6M, up 135% year-over-year.
- Core revenue (ex-COVID) rose 234% YoY to $40.1M in Q4; full year core rev $122.6M (+236%).
- GAAP net income $104.3M ($3.34 EPS) in Q4; full year GAAP net income $507.4M ($16.38 EPS).
- Non-GAAP income $108.7M ($3.48 EPS) in Q4; adjusted EBITDA $159.8M.
- Cash, cash equivalents & marketable securities $935.5M as of Dec 31, 2021; cash from ops $77.1M in Q4.

## SEC filing metadata
- accession: 0001564590-22-006243
- form_type: 8-K
- ticker: FLGT
- cik: 0001674930
- company_name: Fulgent Genetics, Inc.
- filed_at: 2022-02-23T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1674930/000156459022006243/0001564590-22-006243-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1674930/000156459022006243/flgt-8k_20220223.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-006243
- JSON: https://secwatch.observer/filing/0001564590-22-006243.json
- Plain text: https://secwatch.observer/filing/0001564590-22-006243.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.